We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Enliven Therapeutics Inc | NASDAQ:ELVN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.94 | 3.49% | 27.91 | 13.72 | 31.22 | 28.12 | 26.76 | 26.76 | 168,844 | 00:24:02 |
Jefferies Healthcare Conference Format: Podium PresentationDate: Thursday, June 8, 2023Time: 11:00 a.m. ET
The Goldman Sachs Annual Global Healthcare ConferenceFormat: Fireside ChatDate: Wednesday, June 14, 2023Time: 8:00 a.m. PT
Both the presentation and fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company’s website at https://ir.enliventherapeutics.com/. Each webcast will be archived for a period of 30 days following the conclusion of the live event.
About Enliven Therapeutics
Enliven Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer not only live longer, but better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall patient well-being. Enliven’s discovery process combines deep insights in clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies. Enliven is based in Boulder, Colorado.
Contact:
Enliven Investors & Media:Argot PartnersEnliven@argotpartners.com
1 Year Enliven Therapeutics Chart |
1 Month Enliven Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions